Eidogen-Sertanty And Kalypsys, Inc. Establish Drug Discovery Collaboration
SAN DIEGO--(BUSINESS WIRE)--Dec. 14, 2005--Eidogen-Sertanty, Inc., a San Diego-based computational drug discovery solutions provider, today announced that they have established a collaboration with San Diego-based Kalypsys, Inc., focused on the discovery of novel small molecules for anti-inflammatory indications.